It is estimated that about 2 billion people, especially those in lower- and middle-income countries, lack access to quality and affordable essential medicines. The situation is exacerbated by ...
Axmed has received a $6 million in non-dilutive grant funding from the Gates Foundation to expand access to high-quality, affordable medicines ...
BASEL, Switzerland, Dec. 18, 2025 /PRNewswire/ -- Postpartum haemorrhage (PPH), is the leading cause of maternal death in Sub-Saharan Africa. Standard care in these settings often relies on visual ...
Axmed raises $2 million to transform access to critical medicines in low and middle income countries
Axmed’s B2B marketplace aggregates demand for critical medicines in underserved regions to improve the availability, affordability, and distribution of life-saving medicine while extending ...
The provision of affordable medicines to low- and middle-income countries is pitiful, leaving billions of people vulnerable to diseases that could be treated and often cured if they lived in a richer ...
Axmed Secures $6M Grant Funding to Scale the Global Infrastructure for Access to Healthcare Products
BASEL, Switzerland and NAIROBI, Kenya, Feb. 17, 2026 /PRNewswire/ -- Axmed, a health technology company headquartered in Switzerland with regional headquarters in Nairobi, Kenya, today announced it ...
Axmed raises $2 million to transform access to critical medicines in low and middle income countries
For too long, low- and middle-income countries (LMICs) have borne the brunt of global health disparities—accounting for over 80% of the world's population and more than 90% of its disease burden—yet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results